SHG.ASX: Quarterly Activities/Appendix 4C Cash Flow Report

Quarterly Activities/Appendix 4C Cash Flow Report

Stock	Singular Health Group Ltd (SHG.ASX)
Release Time	31 Jul 2026, 11:42 a.m.
Price Sensitive	Yes

This feature provides summaries of price-sensitive announcements for companies followed by users on InvestorPA. The summaries are generated by large language models so please interpret with care.

Singular Health Group Ltd. Q1 FY2026 Activities Report

Key Points

Continued commercial advancement in U.S. with Triple-S and PNS
Successful deployment of 3DICOM in Florida and M-DCPS
Maintained compliance with ISO 27001, HIPAA, and SOC 2 Type II
Strong cash position of $10.1 million
Progressed national phase patent filings for MFTP technology

Full Summary

Singular Health Group Ltd. (ASX: SHG) announced key developments for the quarter ended June 30, 2026. The company engaged in final discussions with Triple-S in Puerto Rico and continued successful negotiations with PNS for contract renewal. Deployments in Florida and Miami-Dade County Public Schools (M-DCPS) were completed, and compliance with ISO 27001, HIPAA, and SOC 2 Type II was maintained. Patent filings for the Medical File Transfer Protocol (MFTP) technology progressed, and the company reported a strong cash position of $10.1 million, providing a runway of close to two years.

Guidance

Strong cash position of $10.1 million, providing a funding runway of close to two years

Outlook

Singular Health expects continued progress across its U.S. commercial opportunities, including finalizing discussions with Triple-S, expanding pilot deployments, and advancing the Florida Statewide Imaging Repository project.